Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein-Reference-Cited by-同舟云学术

Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein

Published:2022-02 Issue: Volume:436 Page:115859
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Zhong Jiahong,Li Mengfan,Xu Jiangping,Dong Wenli,Qin Yunyun,Qiu Shuqing,Li Xing,Wang Haitao

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference53 articles.

1. Hydration thermodynamics of familial Parkinson’s disease-linked mutants of alpha-synuclein;Aggarwal;J. Chem. Inf. Model.,2021

2. Parkin function in Parkinson’s disease;Arkinson;Science,2018

3. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation;Avraham;J. Biol. Chem.,2007

4. Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson’s disease;Banerjee;FEBS Lett.,2010

5. Pannexin 1 channels link chemoattractant receptor signaling to local excitation and global inhibition responses at the front and back of polarized neutrophils;Bao;J. Biol. Chem.,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NKAα1 to treat Parkinson's disease through inhibition of mitophagy-dependent ferroptosis;Free Radical Biology and Medicine;2024-06

2. Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review;Molecular Biology Reports;2024-04-15

3. Involvement of CKS1B in the anti-inflammatory effects of cannabidiol in experimental stroke models;Experimental Neurology;2024-03

4. Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis;Neuropharmacology;2024-01

5. Adenosine A2A receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's disease mice by restoring autophagic flux;Neuroscience Letters;2023-12